Private Advisor Group LLC Has $890,000 Holdings in Masimo Co. (NASDAQ:MASI)

Private Advisor Group LLC boosted its holdings in shares of Masimo Co. (NASDAQ:MASIGet Rating) by 29.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,117 shares of the medical equipment provider’s stock after buying an additional 1,379 shares during the quarter. Private Advisor Group LLC’s holdings in Masimo were worth $890,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of MASI. First Horizon Advisors Inc. boosted its holdings in shares of Masimo by 74.0% during the fourth quarter. First Horizon Advisors Inc. now owns 228 shares of the medical equipment provider’s stock worth $66,000 after acquiring an additional 97 shares during the period. abrdn plc boosted its holdings in shares of Masimo by 3.0% during the fourth quarter. abrdn plc now owns 4,280 shares of the medical equipment provider’s stock worth $1,254,000 after acquiring an additional 123 shares during the period. Eukles Asset Management boosted its holdings in shares of Masimo by 1.3% during the fourth quarter. Eukles Asset Management now owns 10,335 shares of the medical equipment provider’s stock worth $3,026,000 after acquiring an additional 134 shares during the period. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Masimo by 3.8% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 3,974 shares of the medical equipment provider’s stock worth $1,164,000 after acquiring an additional 146 shares during the period. Finally, Pictet Asset Management SA boosted its stake in shares of Masimo by 1.1% in the fourth quarter. Pictet Asset Management SA now owns 18,110 shares of the medical equipment provider’s stock valued at $5,302,000 after buying an additional 190 shares during the period. Institutional investors and hedge funds own 93.31% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. StockNews.com cut Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday, August 10th. Needham & Company LLC boosted their price target on Masimo from $163.00 to $179.00 and gave the company a “buy” rating in a research note on Wednesday, August 10th. Finally, Piper Sandler boosted their price target on Masimo from $130.00 to $135.00 and gave the company a “neutral” rating in a research note on Wednesday, August 10th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $183.80.

Masimo Stock Up 3.7 %

NASDAQ MASI opened at $147.44 on Thursday. The business has a fifty day moving average price of $144.85 and a two-hundred day moving average price of $141.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 2.10 and a quick ratio of 1.28. Masimo Co. has a fifty-two week low of $112.07 and a fifty-two week high of $305.21. The stock has a market capitalization of $7.75 billion, a PE ratio of 44.41 and a beta of 0.96.

Masimo (NASDAQ:MASIGet Rating) last released its earnings results on Tuesday, August 9th. The medical equipment provider reported $1.35 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.16. The firm had revenue of $565.30 million during the quarter, compared to analysts’ expectations of $540.56 million. Masimo had a return on equity of 17.39% and a net margin of 12.68%. The company’s quarterly revenue was up 87.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.94 earnings per share. Equities analysts expect that Masimo Co. will post 4.47 earnings per share for the current fiscal year.

Masimo Company Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIGet Rating).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.